Resource Library

Answering the FDA’s Call: A Practical Discussion for the Implementation of NAMs in Pharma

Presented by Rhiannon Hardwick, PhD, DABT – Scientific Director of Discovery Toxicology, Bristol Myers Squibb, Ajay Yekkirala, PhD – Co-Founder & CSO, Superluminal Medicines, Sam Michael, PhD – VP of Data, Automation, and Predictive Sciences, GSK

Introducing the Emulate Brain-Chip R1: A First-in-Class, Isogenic iPSC Model of the Human Neurovascular Unit

Presented by Erin Greguske, PhD – Senior Scientist, Emulate, Randy Daughters, PhD – Director of Neuroscience and Head of Discovery Biology, Emulate

A New Paradigm for Personalized Cancer Medicine: Predicting Patient-Specific Therapeutic Responses with Organ-on-a-Chip Technology

Presented by Lorenzo Ferri, MD, PhD – Professor of Surgery & Oncology, McGill University, Donald Ingber, MD, PhD – Founding Director and Core Faculty, Wyss Institute at Harvard University

Regulatory Green Light: Using Organ-on-a-Chip Technology to Meet Evolving FDA Expectations

Presented by Daniel Levner, PhD – Chief Technology Officer, Emulate

Beyond Animal Testing: An Evening with Don Ingber

Human Organ-Chips Reveal New Inflammatory Bowel Disease Drivers

Emulate Community Publications Digest: Winter 2026 Issue

January 2026

Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model

Fluids and Barriers of the CNS | January 2026

Gene expression profiling reveals enhanced nutrient and drug metabolism and maturation of hiPSC-derived intestine-on-chip relative to organoids and Transwells

Stem Cell Reports | December 2025

Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome

Advanced Biology | November 2025

Multi-omics qualification of an organ-on-a-chip model of osteolytic bone metastasis

Acta Biomaterialia | November 2025

Establishing the Human Duodenum Chip as a Surrogate for Effective Human Permeability: In Vitro and In Silico Assessment

The AAPS Journal | October 2025

Characterization of the Brain-Chip R1: A First-in-Class, Isogenic Model of the Human Neurovascular Unit

Liver-Chip R1 Application Note

Creating Bone-Chip Models to Discover New Insights into the Mechanisms of Breast Cancer Metastasis

Evaluating CAR T-Cell Therapy Vascular Recruitment, Trafficking & Killing Efficacy with Organ-on-a-Chip Technology

Case Study: Revolutionizing Viral Infectious Disease Research and Drug Discovery with Organ-on-a-Chip Technology

Testing Transduction of AAV-Based Therapeutics on the Liver-Chip

Brain-Chip R1 BioKit Data Sheet

AVA Emulation System Data Sheet

Chip-Array™ Basic Research Kit Data Sheet

Liver-Chip R1 BioKit Data Sheet

Organ-Chip Consumables Selection Chart

Chip-R1™ Basic Research Kit Data Sheet

Validation of minimally-drug-absorbing thermoplastic Chip-R1 Organ-Chip consumable for assessment of liver metabolism and predictive toxicology

Engineering microphysiological systems for investigating airborne infectious diseases

Infection of human alveolar MPS at high containment as a model for pandemic pathogens and assessment of medical countermeasures

Toxicity and mechanisms of uptake and translocation of ingested polystyrene micro-nanoplastics in advanced in vitro small intestinal models

Evaluating the Hepatotoxicity of Cannabidiol, Cannabinol, Cannabichromene and Cannabigerol Using a Human Quad-Culture Liver-Chip

CAR T-Cell Recruitment and Killing can be Evaluated on an Organ-Chip Model System

Emulate Product Brochure

Community Ambassador Program Brochure

Liver Toxicology White Paper: Setting a New Standard in Drug Safety Testing

Improving Inflammatory Disease Drug Development with Organ-on-a-Chip Technology

Improving Gene Therapy Development with Organ-on-a-Chip Technology

An Introduction to Organ-on-a-Chip Technology

Explore the Emulate Organ-Chip Portfolio

Evaluating Solid Tumor CAR T Efficacy with Organ-on-a-Chip Technology

An Unparalleled Window into IBD Immune Response with Organ-on-a-Chip Technology